Lumasiran Effects in Rare Disease Seen Despite Kidney Status Lumasiran Effects in Rare Disease Seen Despite Kidney Status
The first drug to be approved for primary hyperoxaluria type 1 has shown benefit in patients with chronic kidney disease, including those on hemodialysis.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Nephrology News Source Type: news
More News: Chronic Kidney Disease | Dialysis | Drugs & Pharmacology | Hemodialysis | Rare Diseases | Urology & Nephrology